quinoxalines has been researched along with amikacin in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Edwards, CM; Edwards, JR; Gooding, S; Javaid, MK; Leung, SK; Lwin, ST; Nador, G; Olechnowicz, SWZ; Ramasamy, K; Rao, SR; Weivoda, MM | 1 |
1 other study(ies) available for quinoxalines and amikacin
Article | Year |
---|---|
Multiple myeloma increases nerve growth factor and other pain-related markers through interactions with the bone microenvironment.
Topics: Adiponectin; Animals; Bone Marrow; Cell Proliferation; Disease Models, Animal; Gene Expression Regulation, Neoplastic; Humans; Imidazoles; Mice; Multiple Myeloma; Nerve Growth Factor; Neuroglia; NF-kappa B; Osteoblasts; Pain; Peptides; Piperidines; Quinoxalines; Stromal Cells; Tumor Microenvironment; Tumor Necrosis Factor-alpha | 2019 |